Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 17Dermatologic 6Gynecologic 5Thoracic 4Genitourinary 4Gastrointestinal 2CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1Classical hematology 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Burkitt Lymphoma 39Lymphoma, Follicular 37Leukemia, Lymphocytic, Chronic, B-Cell 37Lymphoma, Mantle-Cell 36Lymphoma, B-Cell, Marginal Zone 35Multiple Myeloma 34Lymphoma, Non-Hodgkin 33Lymphoma, Large-Cell, Immunoblastic 33Leukemia, Myeloid, Acute 33Hodgkin Disease 33Lymphoma, Large B-Cell, Diffuse 32Recurrence 30Myelodysplastic Syndromes 29Leukemia 28Myeloproliferative Disorders 27Leukemia, Myeloid, Chronic-Phase 27Congenital Abnormalities 27Lymphoma 26Leukemia, Myeloid, Accelerated Phase 24Lymphoma, Large-Cell, Anaplastic 21Waldenstrom Macroglobulinemia 20Sezary Syndrome 20Mycosis Fungoides 20Leukemia, Myelomonocytic, Chronic 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Myelomonocytic, Juvenile 19Primary Myelofibrosis 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

pembrolizumab 9Gemcitabine 9Cyclophosphamide 8Radiotherapy 7Carboplatin 7Paclitaxel 6Cisplatin 6Trastuzumab 5Irinotecan 5Doxorubicin 5Docetaxel 5Peripheral Blood Stem Cell Transplantation 4Filgrastim 4Capecitabine 4poly ICLC 3pazopanib 3liposomal doxorubicin 3durvalumab 3atezolizumab 3Therapeutics 3Taxes 3Surveys and Questionnaires 3Radiation 3Polymerase Chain Reaction 3Oncolytic Virotherapy 3Letrozole 3Injections 3Fulvestrant 3Fluorodeoxyglucose F18 3Flow Cytometry 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × fludarabine phosphate × Sarcoma × Clear all
NCT00365287 2017-11-29

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Completed
148 enrolled
BreastClassical hematologyGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡